Disease/Infection News

RSS

Study shows how probiotic improves integrity of the GI epithelial cell wall in HIV patients

A newly released study published in the Journal of Immunity, Inflammation and Disease and conducted by the Sapienza University of Rome, Italy, found a multi-strain, high concentration, probiotic formulation that helped reconstitute the physical and immunological integrity of the gastrointestinal lining in HIV-1-positive patients on antiretroviral therapy.

3 May 2017

New analysis shows high mortality and financial burden for pulmonary disease due to non-tuberculosis mycobacterium (NTM)

The first European study into the burden of non-tuberculosis mycobacterium pulmonary disease (NTM-PD), published today in the European Respiratory Journal, has revealed that both the 3-year all-cause mortality rate and financial burden for patients with the disease is almost four times higher than a matched control group.

2 May 2017

Researchers invent promising paper-based technology to kill bacteria and sanitize surfaces

Imagine wearing clothes with layers of paper that protect you from dangerous bacteria. A Rutgers-led team has invented an inexpensive, effective way to kill bacteria and sanitize surfaces with devices made of paper.

2 May 2017

New study shows that gene editing technology can shut down HIV-1 replication in animals

A permanent cure for HIV infection remains elusive due to the virus's ability to hide away in latent reservoirs. But now, in new research published in print May 3 in the journal Molecular Therapy, scientists at the Lewis Katz School of Medicine at Temple University and the University of Pittsburgh show that they can excise HIV DNA from the genomes of living animals to eliminate further infection.

2 May 2017

Researchers develop antibacterial wound dressing made from shells of crustaceans

A new type of wound dressing could improve thousands of people's lives, by preventing them from developing infections. The dressing, a type of compression held in place by a bandage, uses an antibacterial substance formed from the shells of crustaceans like shrimps.

1 May 2017

Researchers find persistence of Zika virus in cerebrospinal fluid, lymph nodes of rhesus monkeys

Zika virus can persist in cerebrospinal fluid (CSF), lymph nodes and colorectal tissue of infected rhesus monkeys for weeks after the virus has been cleared from blood, urine and mucosal secretions, according to a study published online in Cell.

28 Apr 2017

Slender faces linked to overbite and left-handedness

Individuals with a slender lower face are about 25 percent more likely to be left-handed. This unexpected finding (abstract) was identified in 13,536 individuals who participated in three national surveys conducted in the United States.

28 Apr 2017

Study finds significant presence of multidrug-resistant bacteria among nursing home residents

The significant presence of multidrug-resistant gram-negative bacteria, such as E. coli, among nursing home residents demonstrates the need for heightened infection control prevention and control measures in nursing homes, according to a meta-analysis published in the May issue of the American Journal of Infection Control, the official journal of the Association for Professionals in Infection Control and Epidemiology.

27 Apr 2017

Alere introduces first-ever highly sensitive malaria test for asymptomatic infections

Alere Inc., a global leader in rapid diagnostics, today announced the launch of its Alere™ Malaria Ag P.f, a major technological breakthrough in high-sensitivity rapid testing versus currently available malaria RDTs.

27 Apr 2017

Researchers identify new antibiotic resistance gene in bacteria from dairy cows

Researchers of the University of Bern have identified a new antibiotic resistance gene in bacteria from dairy cows. This gene confers resistance to all beta-lactam antibiotics including the last generation of cephalosporins used against methicillin-resistant Staphylococcus aureus.

26 Apr 2017

Scientists aim to combat antibiotic-resistant infections by harnessing synthetic mucus

Researchers are pursuing an innovative and unexpected new avenue in the quest to fight antibiotic resistance: synthetic mucus. By studying and replicating mucus' natural ability to control pathogenic bacteria, the scientists hope to find new methods for combating infections.

26 Apr 2017

Early blood test can predict vaccine immunogenicity

Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect.

26 Apr 2017

New study aims at making accessible epidemiological models for managing disease spread

A new computer modeling study from Los Alamos National Laboratory is aimed at making epidemiological models more accessible and useful for public health collaborators and improving disease-related decision making.

26 Apr 2017

WHO/AFRO: Ghana, Kenya, and Malawi to participate in malaria vaccine pilot program

The World Health Organization Regional Office for Africa announced today that Ghana, Kenya, and Malawi will take part in a WHO-coordinated malaria vaccine implementation programme (MVIP) that will make the world’s first malaria vaccine available in selected areas, beginning in 2018.

26 Apr 2017

New field laboratory-deployed molecular test could eliminate malaria

As the global community gathers for World Malaria Day to celebrate successes and plot strategy to eliminate the disease from the face of the earth, a new ray of hope is emerging from a surprising place: the testing side of the equation.

26 Apr 2017

New class of drugs offers hope against antibiotic resistance

Polyphor today presented promising data for their novel class of antibiotics, the Outer Membrane Protein Targeting Antibiotics (OMPTA). This is the first new class of antibiotic against Gram-negative pathogens to reach advanced clinical development in over 40 years.

26 Apr 2017

Researchers use novel phage therapy to treat patient infected with multidrug-resistant bacterium

Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center - Biological Defense Research Directorate, Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages -- viruses that target and consume specific strains of bacteria -- to treat a patient near death from a multidrug-resistant bacterium.

25 Apr 2017

Disease/Infection News

Study shows how probiotic improves integrity of the GI epithelial cell wall in HIV patients

New analysis shows high mortality and financial burden for pulmonary disease due to non-tuberculosis mycobacterium (NTM)

Researchers invent promising paper-based technology to kill bacteria and sanitize surfaces

New study shows that gene editing technology can shut down HIV-1 replication in animals

Researchers develop antibacterial wound dressing made from shells of crustaceans

Researchers find persistence of Zika virus in cerebrospinal fluid, lymph nodes of rhesus monkeys

Slender faces linked to overbite and left-handedness

Study finds significant presence of multidrug-resistant bacteria among nursing home residents

Alere introduces first-ever highly sensitive malaria test for asymptomatic infections

Researchers identify new antibiotic resistance gene in bacteria from dairy cows

Scientists aim to combat antibiotic-resistant infections by harnessing synthetic mucus

Early blood test can predict vaccine immunogenicity

New study aims at making accessible epidemiological models for managing disease spread

WHO/AFRO: Ghana, Kenya, and Malawi to participate in malaria vaccine pilot program

New field laboratory-deployed molecular test could eliminate malaria

New class of drugs offers hope against antibiotic resistance

Researchers use novel phage therapy to treat patient infected with multidrug-resistant bacterium

Scientists create new technique for studying how chlamydia interacts with immune system

Return of malaria in the U.S. is costing millions, study claims

UC Santa Cruz researcher identifies major gaps that must be filled in to control Lyme disease

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News